株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

幹細胞療法の世界市場:タイプ別、最終用途別、細胞源別、エンドユーザー別、地域別の分析、シェア、動向、市場規模(2020年~2026年)

Stem Cell Therapy Market, by Types, by Application, by Cell Source, by End-Use, and by Geography - Analysis, Share, Trends, Size, & Forecast From 2020 - 2026

発行 AnalystView Market Insights 商品コード 930161
出版日 ページ情報 英文 206 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=108.69円で換算しております。
幹細胞療法の世界市場:タイプ別、最終用途別、細胞源別、エンドユーザー別、地域別の分析、シェア、動向、市場規模(2020年~2026年) Stem Cell Therapy Market, by Types, by Application, by Cell Source, by End-Use, and by Geography - Analysis, Share, Trends, Size, & Forecast From 2020 - 2026
出版日: 2020年03月01日 ページ情報: 英文 206 Pages
概要

幹細胞療法は、組織の修復と再生を通じて臓器の機能を改善する治療法であり、糖尿病、脊髄損傷、パーキンソン病、アルツハイマー病、がん、心臓病、変形性関節症など様々な疾病の治療に用いられるほか、中枢神経系疾患、眼疾患、創傷や損傷、筋骨格系疾患、代謝障害、周期性嘔吐症候群、免疫系障害などの治療に応用するための研究開発も進められています。

当レポートは、世界の幹細胞療法市場を調査したもので、 業界と市場の状況、タイプ別、最終用途別、細胞源別、エンドユーザー別、地域別の分析、主要ベンダーの分析などの情報を提供しています。

目次

第1章 市場の概要

  • 調査範囲
  • 前提条件と調査方法

第2章 エグゼクティブサマリー

第3章 市場の主な動向

  • 成長促進要因
    • 成長促進要因の影響分析
  • 成長阻害要因
    • 成長阻害要因の影響分析
  • 市場機会
  • 市場の将来動向

第4章 業界分析

  • ポーターのファイブフォース分析
  • マーケティング戦略分析
  • 成長見込みのマッピング
  • 規制の枠組みの分析

第5章 市場の情勢

  • 市場シェア分析
  • 主なイノベーター
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第6章 市場分析:タイプ別

  • 概要
    • セグメントシェア分析:タイプ別(2019年と2026年)
  • 自己幹細胞療法
  • 同種幹細胞療法

第7章 市場分析:最終用途別

  • 概要
    • セグメントシェア分析:最終用途別(2019年と2026年)
  • 眼病
  • 創傷、損傷
  • 中枢神経系疾患
  • 心血管疾患
  • 代謝異常
  • 腫瘍
  • 筋骨格系疾患
  • 免疫系障害

第8章 市場分析:細胞源別

  • 概要
    • セグメントシェア分析:細胞源別(2019年と2026年)
  • 臍帯血/胚性幹細胞
  • 脂肪組織由来の間葉系幹細胞
  • 骨髄由来の間葉系幹細胞
  • その他

第9章 市場分析:エンドユーザー別

  • 概要
    • セグメントシェア分析:エンドユーザー別(2019年と2026年)
  • 外来外科センター
  • 病院
  • その他

第10章 市場分析:地域別

  • イントロダクション
    • セグメントシェア分析:地域別(2019年と2026年)
  • 北米
    • 概要
    • 主要メーカー
    • 市場規模と予測:国別
    • 市場規模と予測:タイプ別
    • 市場規模と予測:最終用途別
    • 市場規模と予測:細胞源別
    • 市場規模と予測:エンドユーザー別
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • その他
  • アジア太平洋
    • インド
    • 中国
    • 日本
    • 韓国
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
    • その他
  • 中東・アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第11章 ベンダーの分析

  • Mesoblast Ltd.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的取り組み
  • Vericel Corporation
  • Gamida Cell
  • Stem Cells, Inc.
  • Chiesi Farmaceutici SpA
  • Osiris Therapeutics、Inc.
  • ReNeuron Group、plc。

第12章 ANALYSTVIEWについて

第13章 付録

  • 調査手法
  • 参考文献
  • 略語
  • 免責事項
  • お問い合わせ
図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Stem Cell Therapy market: Type Snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Stem Cell Therapy market, by Type 2015-2026 (USD Million)
  • TABLE Stem Cell Therapy market: End Use Snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by End Use
  • TABLE Global Stem Cell Therapy market, by End Use 2015-2026 (USD Million)
  • TABLE Stem Cell Therapy market: Cell Source Snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Cell Source
  • TABLE Global Stem Cell Therapy market, by Cell Source 2015-2026 (USD Million)
  • TABLE Stem Cell Therapy market: End Use Snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by End Use
  • TABLE Global Stem Cell Therapy market, by End Use 2015-2026 (USD Million)
  • TABLE Stem Cell Therapy market: Regional snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Stem Cell Therapy market, by Region 2015-2026 (USD Million)
  • TABLE North America Stem Cell Therapy market, by Country, 2015-2026 (USD Million)
  • TABLE North America Stem Cell Therapy market, by Type, 2015-2026 (USD Million)
  • TABLE North America Stem Cell Therapy market, by End Use, 2015-2026 (USD Million)
  • TABLE North America Stem Cell Therapy market, by Cell Source, 2015-2026 (USD Million)
  • TABLE North America Stem Cell Therapy market, by End Use, 2015-2026 (USD Million)
  • TABLE Europe Stem Cell Therapy market, by country, 2015-2026 (USD Million)
  • TABLE Europe Stem Cell Therapy market, by Type, 2015-2026 (USD Million)
  • TABLE Europe Stem Cell Therapy market, by End Use, 2015-2026 (USD Million)
  • TABLE Europe Stem Cell Therapy market, by Cell Source, 2015-2026 (USD Million)
  • TABLE Europe Stem Cell Therapy market, by End Use, 2015-2026 (USD Million)
  • TABLE Asia Pacific Stem Cell Therapy market, by country, 2015-2026 (USD Million)
  • TABLE North America Stem Cell Therapy market, by Type, 2015-2026 (USD Million)
  • TABLE Asia Pacific Stem Cell Therapy market, by End Use, 2015-2026 (USD Million)
  • TABLE Asia Pacific Stem Cell Therapy market, by Cell Source, 2015-2026 (USD Million)
  • TABLE Asia Pacific Stem Cell Therapy market, by End Use, 2015-2026 (USD Million)
  • TABLE Latin America Stem Cell Therapy market, by country, 2015-2026 (USD Million)
  • TABLE Latin America Stem Cell Therapy market, by Type, 2015-2026 (USD Million)
  • TABLE Latin America Stem Cell Therapy market, by End Use, 2015-2026 (USD Million)
  • TABLE Latin America Stem Cell Therapy market, by Cell Source, 2015-2026 (USD Million)
  • TABLE Latin America Stem Cell Therapy market, by End Use, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Stem Cell Therapy market, by country, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Stem Cell Therapy market, by Type, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Stem Cell Therapy market, by End Use, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Stem Cell Therapy market, by Cell Source, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Stem Cell Therapy market, by End Use, 2015-2026 (USD Million)

List of Figures

  • FIGURE Stem Cell Therapy market segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE Competitive Landscape; Key company market share analysis, 2018
  • FIGURE Type segment market share analysis, 2019 & 2026
  • FIGURE Type segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Autologous Stem Cell Therapy market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Allogeneic Stem Cell Therapy market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Application segment market share analysis, 2019 & 2026
  • FIGURE Application segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Eye Diseases market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Wound & Injuries market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Central Nervous System Diseases market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Cardiovascular Disorders market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Metabolic Disorders market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Oncology market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Musculoskeletal Diseases market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Immune System Disorders market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Cell Source segment market share analysis, 2019 & 2026
  • FIGURE Cell Source segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Cord Blood/Embryonic Stem Cells market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Adipose tissue-derived Mesenchymal Stem Cells market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Bone Marrow-derived Mesenchymal Stem Cells market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Other Cell Sources market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE End Use segment market share analysis, 2019 & 2026
  • FIGURE End Use segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Ambulatory Surgical Centers market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Hospitals market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Others market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Regional segment market share analysis, 2019 & 2026
  • FIGURE Regional segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE North America Stem Cell Therapy market share and leading players, 2018
  • FIGURE Europe Stem Cell Therapy market share and leading players, 2018
  • FIGURE Asia Pacific Stem Cell Therapy market share and leading players, 2018
  • FIGURE Latin America Stem Cell Therapy market share and leading players, 2018
  • FIGURE Middle East and Africa Stem Cell Therapy market share and leading players, 2018
  • FIGURE North America Stem Cell Therapy market share analysis by country, 2018
  • FIGURE U.S. Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Canada Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Europe Stem Cell Therapy market share analysis by country, 2018
  • FIGURE Germany Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Spain Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Italy Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE UK Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE France Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Rest of the Europe Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Asia Pacific Stem Cell Therapy market share analysis by country, 2018
  • FIGURE India Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE China Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Japan Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE South Korea Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Singapore Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Rest of APAC Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Latin America Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Latin America Stem Cell Therapy market share analysis by country, 2018
  • FIGURE Brazil Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Mexico Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Argentina Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Rest of LATAM Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Middle East and Africa Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Middle East and Africa Stem Cell Therapy market share analysis by country, 2018
  • FIGURE Saudi Arabia Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE United Arab Emirates Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
目次

REPORT HIGHLIGHT

The stem cell therapy market was valued at USD XX billion by 2018, growing with XX% CAGR during the forecast period, 2020-2026

Market Dynamics

Stem cell therapy is a rapidly advancing branch of medicine that involves repair and regeneration of tissues to improve the organ function. This therapy has gained global recognition as one of the promising breakthroughs in natural healing and renewal. Stem cell therapy is used for the treatment of various life-threatening disorders such as diabetes, spinal cord injuries Parkinson's & Alzheimer's disease, cancer, heart disease, and osteoarthritis. Advancements and innovation in stem cell therapy has been trending subject in the past decade. Stem cell research also includes collecting data and using the data to benefit potential organ transplant patients.

One of the biggest applications of stem cell therapy is its use in organ transplant and tissue regeneration. According to the National Centre of Biotechnology Information (August 2017), cell therapy has been showing promising results in solid organ transplantation and is known to be safe and feasible in clinical trials. Thus, the demand for stem cell therapy is anticipated to increase in future. In addition to this, rising number for patients demanding organ transplantation support the industry growth. Based on data published in a National Stem Cell Foundation (NSCF), approximately 115,000 patients are on the waitlist for life-saving organ transplantation surgeries.

Furthermore, a transplant study led by DRI Federation center at Xiamen University in China and scientists from the Diabetes Research Institute at the Miller School showed that mesenchymal stem cells exhibits strong potential to replace a powerful anti-rejection therapeutics in transplant recipient. This study was published by the University of Miami Health System in February 2020. This benefits remains the key driver for the growth of the stem cell therapy industry. On the other side, unclear and ambiguous regulatory guidelines for stem cell research and application will pull back the industry growth to some extent.

Types Takeaway

In terms of types, the industry is segmented as autologous, and allogeneic stem cell therapy. Among these, the allogeneic stem cell therapy dominates the worldwide stem cell therapy market. The primary reason why allogeneic stem cell therapy governs this market is due to its wide range of applications and its ease of commercialization in clinical trials. An article published in 'healio.com' (December 2018) stated, that allogeneic therapy helps in reducing the risk of relapsed follicular lymphoma.

Application Takeaway

In terms of application, the stem cell therapy industry is broadly studied into CNS diseases, oncology, eye diseases¸ wound & injuries, musculoskeletal diseases, metabolic disorders, CVS and immune system disorders. Among the mentioned applications, the CNS category held the largest market share owing to the rising CNS disorders coupled with lack of effective treatment therapies. In November 2017, the article published by the Biopharma Dealmakers stated that there is a lack of successful curative therapies for the treatment of Alzheimer's, Huntington's, and Parkinson's disease. This stem cell therapy has uplifted and firmly positioned its use to replace the damaged neurons thereby offers great hope for patients with neurodegenerative disorders.

Cell Source Takeaway

Based on the cell source segment, the industry is segmented into bone marrow-derived, adipose tissue-derived mesenchymal, and cord blood/embryonic stem cells. Within this category, the adipose tissue-derived segment accounted for maximum revenue share in 2018 and is projected to grow with promising growth rate during the forecast period. With respect to the fastest-growing category, bone marrow-derived means in mesenchymal stem cell leads undoubtedly. This cell source types are essential in providing support to the differentiation and growth of primitive hemopoietic tissues within the bone marrow microenvironment.

End-Use Takeaway

Hospitals and ambulatory surgical centres are the two end-users category analysed in this report. Among which, hospitals captured significant revenue share in 2018 and is anticipated to continue its dominance over the study period. Whereas, ambulatory surgical centres will be the fastest growing category during the projection period. Availability of centres such as Advanced Ambulatory Surgery Center (AASC) that offers world-class facility to physicians to perform stem cell procedures supports the segment growth to certain extent.

Regional Takeaway

Regionally, the North America is the most developed and dominant market with regards to stem cell therapy. This can be attributed to the rising research and development activity in the U.S market. Earlier, President Clinton had signed a law that banned Federal funding in research that was associated with destroying human embryos. In March 2019, then President Mr Obama issued an order that would favor the human embryonic stem cell research. In addition to this, as per the Charlotte Lozier Institute website (February 2018), approximately USD 131 million were allocated to human embryonic stem cell research whereas, 861 million dollar was attributed to non-embryonic stem cell research. Such favourable government initiatives would in turn help this region to grow considerably and provides path-breaking discoveries in the regenerative medicine category. The Asia Pacific follows the lead and is expected to be one of the fastest-growing markets over the forecast.

Key Vendor Takeaway

The key players that dominate the market in this category are, Mesoblast Ltd., Vericel Corporation, Gamida Cell, Stem Cells, Inc., Chiesi Farmaceutici S.p.A., Osiris Therapeutics, Inc. and ReNeuron Group, plc. Osiris therapeutics announced the completion of its acquisition by a Smith and Nephew PLC. In fact, in 2015, Chiesi Pharmaceutical drug that is an advanced stem cell therapy based medicinal product which is first of its kind was approved in Europe.

The market size and forecast for each segment and sub-segments has been considered as below:

Historical Year - 2015 to 2018

Base Year - 2019

Estimated Year - 2020

Projected Year - 2026

TARGET AUDIENCE

Traders, Distributors, and Suppliers

Manufacturers

Government and Regional Agencies

Research Organizations

Consultants

Distributors

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

KEY PLAYERS

Mesoblast Ltd.

Vericel Corporation

Gamida Cell

Stem Cells, Inc.

Chiesi Farmaceutici S.p.A.

Osiris Therapeutics, Inc.

ReNeuron Group, plc.

MARKET, BY TYPES

Autologous Stem Cell Therapy

Allogeneic Stem Cell Therapy

MARKET, BY APPLICATION

Eye Diseases

Wound & Injuries

Central Nervous System Diseases

Cardiovascular Disorders

Metabolic Disorders

Oncology

Musculoskeletal Diseases

Immune System Disorders

MARKET, BY CELL SOURCE

Cord Blood/Embryonic Stem Cells

Adipose Tissue-derived Mesenchymal Stem Cells

Bone Marrow-derived Mesenchymal Stem Cells

Other Cell Sources

MARKET, BY END-USE

Ambulatory Surgical Centers

Hospitals

Others

MARKET, BY REGION

North America

The U.S.

Canada

Europe

Germany

France

Italy

Spain

United Kingdom

Rest of Europe

Asia Pacific

India

China

South Korea

Japan

Singapore

Rest of APAC

Latin America

Brazil

Mexico

Argentina

Rest of LATAM

Middle East and Africa

Saudi Arabia

United Arab Emirates

Rest of MEA

TABLE OF CONTENT

1. STEM CELL THERAPY MARKET OVERVIEW

  • 1.1. Study Scope
  • 1.2. Assumption and Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Market Snippet
    • 2.1.1. Market Snippet by Type
    • 2.1.2. Market Snippet by End Use
    • 2.1.3. Market Snippet by Cell Source
    • 2.1.4. Market Snippet by End Use
    • 2.1.5. Market Snippet by Region
  • 2.2. Competitive Insights

3. STEM CELL THERAPY KEY MARKET TRENDS

  • 3.1. Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Future Trends

4. STEM CELL THERAPY INDUSTRY STUDY

  • 4.1. Porter's Five Forces Analysis
  • 4.2. Marketing Strategy Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. STEM CELL THERAPY MARKET LANDSCAPE

  • 5.1. Market Share Analysis
  • 5.2. Key Innovators
  • 5.3. Breakdown Data, by Key manufacturer
    • 5.3.1. Established Player Analysis
    • 5.3.2. Emerging Player Analysis

6. STEM CELL THERAPY MARKET - BY TYPE

  • 6.1. Overview
    • 6.1.1. Segment Share Analysis, By Type, 2019 & 2026 (%)
  • 6.2. Autologous Stem Cell Therapy
    • 6.2.1. Overview
    • 6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 6.3. Allogeneic Stem Cell Therapy
    • 6.3.1. Overview
    • 6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

7. STEM CELL THERAPY MARKET - BY END USE

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By End Use, 2019 & 2026 (%)
  • 7.2. Eye Diseases
    • 7.2.1. Overview
    • 7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 7.3. Wound & Injuries
    • 7.3.1. Overview
    • 7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 7.4. Central Nervous System Diseases
    • 7.4.1. Overview
    • 7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 7.5. Cardiovascular Disorders
    • 7.5.1. Overview
    • 7.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 7.6. Metabolic Disorders
    • 7.6.1. Overview
    • 7.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 7.7. Oncology
    • 7.7.1. Overview
    • 7.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 7.8. Musculoskeletal Diseases
    • 7.8.1. Overview
    • 7.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 7.9. Immune System Disorders
    • 7.9.1. Overview
    • 7.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

8. STEM CELL THERAPY MARKET - BY CELL SOURCE

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Cell Source, 2019 & 2026 (%)
  • 8.2. Cord Blood/Embryonic Stem Cells
    • 8.2.1. Overview
    • 8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 8.3. Adipose Tissue-derived Mesenchymal Stem Cells
    • 8.3.1. Overview
    • 8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 8.4. Bone Marrow-derived Mesenchymal Stem Cells
    • 8.4.1. Overview
    • 8.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 8.5. Other Cell Sources
    • 8.5.1. Overview
    • 8.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

9. STEM CELL THERAPY MARKET - BY END USE

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End Use, 2019 & 2026 (%)
  • 9.2. Ambulatory Surgical Centres
    • 9.2.1. Overview
    • 9.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 9.3. Hospitals
    • 9.3.1. Overview
    • 9.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 9.4. Others
    • 9.4.1. Overview
    • 9.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

10. STEM CELL THERAPY MARKET- BY GEOGRAPHY

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Region, 2019 & 2026 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2015 - 2026 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Cell Source, 2015 - 2026 (US$ Million)
    • 10.2.7. North America Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)
    • 10.2.8. U.S.
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.2.9. Canada
      • 10.2.9.1. Overview
      • 10.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2015 - 2026 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Cell Source, 2015 - 2026 (US$ Million)
    • 10.3.7. Europe Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)
    • 10.3.8. Germany
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.3.9. Italy
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.3.10. United Kingdom
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.3.11. France
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.3.12. Rest of Europe
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2015 - 2026 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Cell Source, 2015 - 2026 (US$ Million)
    • 10.4.7. Asia Pacific Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.4.9. China
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.4.10. Japan
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.4.11. South Korea
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.4.12. Rest of APAC
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2015 - 2026 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Cell Source, 2015 - 2026 (US$ Million)
    • 10.5.7. Latin America Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)
    • 10.5.8. Brazil
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.5.9. Mexico
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.5.10. Argentina
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2015 - 2026 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Cell Source, 2015 - 2026 (US$ Million)
    • 10.6.7. Middle East and Africa Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)
    • 10.6.8. Saudi Arabia
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.6.9. United Arab Emirates
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

11. KEY VENDOR ANALYSIS

  • 11.1. Mesoblast Ltd.
    • 11.1.1. Company Snapshot
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Strategic Initiatives
  • 11.2. Vericel Corporation
  • 11.3. Gamida Cell
  • 11.4. Stem Cells, Inc.
  • 11.5. Chiesi Farmaceutici S.p.A.
  • 11.6. Osiris Therapeutics, Inc.
  • 11.7. ReNeuron Group, plc.

12. 360 DEGREE ANALYSTVIEW

13. APPENDIX

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us